[5] Alongside Susie Green, the former CEO of Mermaids, GenderGP launched a charitable fund in February 2023 to provide gender-affirming health care to young trans people through the clinic's services.
The statement in the ruling was based on evidence from Dr Jacqueline Hewitt, consultant paediatric endocrinologist, who said there was no physical examination of the patient, no skeletal bone age x-ray and bone densitometry investigation, a single 'extremely poor quality' psychological assessment with an unregistered counsellor, and "no record of counselling regarding the known risks of hormone treatment for gender dysphoria".
[13][14][15] Dr. Hewitt also stated that Gender GP had followed a "highly abnormal and frankly negligent approach" by prescribing an immediate "top-end dosage to a testosterone-naïve child" such that "the level of testosterone in the blood was 'dangerously high' and that, apart from the potential for adverse long-term consequences of such a level, J was 'presently at risk of sudden death due to thromboembolic disease".
[18][19] The tribunal also found that her fitness to practice was impaired, saying she had failed to provide adequate advice to a 11-year-old patient about the risks to fertility arising from treatment.
[24][25] In May 2019 the GMC issued an interim suspension order against Mike, stating that the care he provided "fell below the standards expected".
[26] A subsequent MPTS hearing found Mike had acted outside the limits of his expertise when providing treatment to seven transgender patients of GenderGP.
[25] Although the tribunal noted that he had not been subject to any previous disciplinary findings, it concluded that his conduct was incompatible with registration as a doctor, and struck his name from the medical register.